<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://iatistandard.org/downloads/iati-activities-schema.xsd">
  <iati-identifier>US-EIN-300108263-GGProj:19809</iati-identifier>
  <reporting-org ref="US-EIN-300108263" type="21">
   <narrative xml:lang="EN">GlobalGiving</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Pursuing new treatments for Neuroblastoma children</narrative>
  </title>
  <description>
   <narrative xml:lang="EN">Cure First is tackling neuroblastoma (NB), a childhood cancer for which survival is poor and current treatments are overshadowed by side effects. Despite this,  NB has not attracted the focus of the pharmaceutical industry. Recently we were able to establish patient-derived organoids and to apply high-throughput robotic tools to highlight drug sensitivities. We are now raising funds to finance an in vivo study which will help validate our findings and prepare them for a clinical trial.</narrative>
  </description>
  <participating-org ref="US-EIN-300108263" role="1" type="21"></participating-org>
  <participating-org ref="XI-BRIDGE-2182666267" role="4"></participating-org>
  <other-identifier ref="19809">
   <owner-org ref="US-EIN-300108263"></owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2015-03-16" type="1"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">Cure First</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">Carla Grandori</narrative>
   </person-name>
   <telephone>206-854-2305</telephone>
   <mailing-address>
    <narrative xml:lang="EN">Carla Grandori, 1920 38TH Ave E, Seattle, WA 98112, United States</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="US" percentage="100"></recipient-country>
  <sector code="P30" percentage="100" vocabulary="5"></sector>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <transaction ref="US-EIN-300108263-GGProj:19809">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-30"></transaction-date>
   <value currency="USD" value-date="2020-07-30">24607</value>
   <provider-org ref="US-EIN-300108263"></provider-org>
   <receiver-org ref="XI-BRIDGE-2182666267"></receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <document-link format="TEXT/HTML" url="https://www.globalgiving.org/projects/in-vivo-validation-for-neuroblastoma/">
   <title>
    <narrative xml:lang="EN">Activity website</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <conditions attached="0"></conditions>
 </iati-activity>
</iati-activities>
